NasdaqCM - Nasdaq Real Time Price USD

Kineta, Inc. (KA)

0.4671 +0.0171 (+3.83%)
As of 1:23 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
5,161.0000
5,442.0000
1,041.0000
9,091.0000
10,488.0000
Operating Expense
20,804.0000
21,165.0000
42,572.0000
20,184.0000
13,603.0000
Operating Income
-15,643.0000
-15,723.0000
-41,531.0000
-11,093.0000
-3,115.0000
Net Non Operating Interest Income Expense
-37.0000
-12.0000
-3,728.0000
-1,293.0000
-4,960.0000
Other Income Expense
-2,165.0000
1,659.0000
-18,194.0000
569.0000
963.0000
Pretax Income
-17,845.0000
-14,076.0000
-63,453.0000
-11,817.0000
-7,112.0000
Net Income Common Stockholders
-17,886.0000
-14,099.0000
-63,408.0000
-11,817.0000
-8,052.0000
Diluted NI Available to Com Stockholders
-17,886.0000
-14,099.0000
-63,408.0000
-11,817.0000
-8,052.0000
Basic EPS
-1.40
--
-12.87
-2.71
-1.67
Diluted EPS
-1.40
--
-12.87
-2.71
-1.67
Basic Average Shares
11,824.5000
--
4,926.0000
4,358.0000
4,808.0000
Diluted Average Shares
11,824.5000
--
4,926.0000
4,358.0000
4,808.0000
Total Operating Income as Reported
-15,643.0000
-15,723.0000
-41,531.0000
-11,093.0000
-3,115.0000
Total Expenses
20,804.0000
21,165.0000
42,572.0000
20,184.0000
13,603.0000
Net Income from Continuing & Discontinued Operation
-17,886.0000
-14,099.0000
-63,408.0000
-11,817.0000
-8,052.0000
Normalized Income
-15,636.0000
-15,681.0000
-63,749.0000
-13,536.0000
-8,150.0000
Interest Income
319.0000
325.0000
9.0000
--
--
Interest Expense
356.0000
337.0000
3,737.0000
1,293.0000
4,960.0000
Net Interest Income
-37.0000
-12.0000
-3,728.0000
-1,293.0000
-4,960.0000
EBIT
-17,489.0000
-13,739.0000
-59,716.0000
-10,524.0000
-2,152.0000
EBITDA
-17,482.0000
-13,730.0000
-59,643.0000
-10,445.0000
-1,994.0000
Reconciled Depreciation
7.0000
9.0000
73.0000
79.0000
158.0000
Net Income from Continuing Operation Net Minority Interest
-17,886.0000
-14,099.0000
-63,408.0000
-11,817.0000
-8,052.0000
Total Unusual Items Excluding Goodwill
-2,250.0000
1,582.0000
341.0000
1,719.0000
98.0000
Total Unusual Items
-2,250.0000
1,582.0000
341.0000
1,719.0000
98.0000
Normalized EBITDA
-15,232.0000
-15,312.0000
-59,984.0000
-12,164.0000
-2,092.0000
12/31/2020 - 2/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VIRI Virios Therapeutics, Inc.
0.2124
-6.84%
 
XCUR Exicure, Inc.
0.3416
-14.26%
 
FRES Fresh2 Group Limited
0.4174
-4.49%
 
INM InMed Pharmaceuticals Inc.
0.2229
-5.31%
 
GRI GRI Bio, Inc.
0.2689
-3.41%
 
FBLG FibroBiologics, Inc.
9.10
-5.11%
 
SILO Silo Pharma, Inc.
1.1550
-0.43%
 
PRTG Portage Biotech Inc.
0.2699
+0.11%
 
LGVN Longeveron Inc.
1.0750
+3.38%
 
VIGL Vigil Neuroscience, Inc.
4.4701
-2.82%